The escalating global Mpox outbreak has been met with a concerning revelation. Two distinct studies have indicated that the ...

Two recent studies reveal that the efficacy of Bavarian Nordic's Mpox vaccine significantly declines within 6-12 months ...

最常用的mpox疫苗提供对该疾病的部分免疫，但并不总是能够预防严重症状或疾病传播。与目前许可的改良安卡拉牛痘 (MVA)疫苗相比，Moderna公司的一种新的mRNA候选疫苗mRNA-1769更有效地限制了感染m痘病毒致死株的灵长类动物的症状和疾病持续时间。

Amid the rising global outbreak of Mpox, two separate studies have shown that the efficacy of Bavarian Nordic’s vaccine ...

M痘的爆发，不只让社会重新检视自身的防疫和保健意识，也让大众注意到社会上鲜为人知的暗角，躲藏着一些大多数人平时不愿意讨论和面对的歧视、厌恶和不平等。今年8月中，世界卫生组织（WHO）宣布由非洲地区（包括刚果、中非和西非等区域）开始爆发的M痘疫情，为“ ...

With more than 200 mpox-related deaths reported globally, the EMA has approved Imvanex for adolescents aged 12-17 years.

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) vaccine is moderately effective against mpox infection in at-risk communities.

The rate of mpox infection in the vaccinated group was 0.09 for every 1,000 person-days as compared to 0.20 in the ...

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix ...

One dose of modified vaccinia Ankara-Bavarian Nordic (MVA-BN) smallpox vaccine is moderately effective in preventing mpox ...

"This study reinforces the benefit in vaccinating against mpox with MVA-BN and reaffirms that a single dose provides at least ...

One dose of modified vaccinia Ankara-Bavarian Nordic vaccine is moderately effective against mpox infection in at-risk communities.